The call may provide clarity on LIBERTY commercial traction and rebut negative press, but no hard data is available yet. Traders should watch for any revenue or adoption metrics disclosed during the May 18 call.
Price Chart
Executive Summary
Microbot Medical filed an 8-K announcing a conference call on May 18, 2026, to address what it calls misleading statements in an unaffiliated third-party article about its LIBERTY Endovascular Robotic System. The call will feature current LIBERTY users Dr. Charles Briggs and Dr. Zachary Bercu, who will refute inaccuracies attributed to them. A Wall Street firm has also published a research report supporting the company's position. No financial data or guidance is provided.
Key Facts
- Conference call scheduled for Monday, May 18, 2026 at 3:00pm ET to address an unaffiliated third-party article.
- Dr. Charles Briggs (Tampa General Hospital) and Dr. Zachary Bercu (Emory Healthcare), current LIBERTY users, will participate to correct alleged inaccuracies.
- A Wall Street firm published a research report refuting claims in the third-party article.
- No financial results, guidance, or material quantitative data disclosed.
- Company has a $124M market cap and 89% analyst bullish consensus.
Financial Impact
No financial figures disclosed in the filing.
Risk Factors
- The third-party article may contain valid concerns about LIBERTY adoption or performance that the call cannot fully rebut.
- No financial data means the filing provides no fundamental catalyst; stock may drift lower as it has after prior neutral filings.
- Conference call may fail to provide concrete commercial metrics, disappointing bullish expectations.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-023493 |
| Exhibit: ex99-1.htm | 0001493152-26-023493 |
| Document: 0001493152-26-023493-index-headers.html | 0001493152-26-023493 |
| Document: 0001493152-26-023493-index.html | 0001493152-26-023493 |
| Document: 0001493152-26-023493.txt | 0001493152-26-023493 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | 8-K | $0.9739 $0.9417 | ▼ −3.31% | ▼ −4.02% | $0.9400 (−3.48%) |
Oct 20, 2026 6d ago | 8-K | $0.9475 $0.9401 | ▼ −0.78% | ▼ −1.31% | $0.9400 (−0.79%) |
Oct 6, 2026 20d ago | 8-K | $1.07 $1.12 | ▲ +4.67% | ▲ +4.91% | $0.9400 (−12.15%) |
Oct 6, 2026 20d ago | Press Release | $1.07 $1.12 | ▲ +4.67% | ▲ +4.91% | $0.9400 (−12.15%) |
Sep 28, 2026 28d ago | 8-K | $1.25 $1.25 | ▼ −0.40% | ▼ −0.22% | $0.9400 (−24.80%) |
Aug 11, 2026 10w ago | 8-K | $1.68 $1.74 | ▲ +3.27% | ▲ +3.02% | $0.9400 (−44.05%) |
Jul 21, 2026 13w ago | 8-K | $1.80 $1.77 | ▼ −1.67% | ▼ −1.55% | $0.9400 (−47.78%) |
Jul 7, 2026 15w ago | 8-K | $1.90 $1.87 | ▼ −1.58% | ▼ −1.27% | $0.9400 (−50.53%) |
Jun 30, 2026 16w ago | 8-K | $1.95 $1.91 | ▼ −2.05% | ▼ −1.92% | $0.9400 (−51.79%) |
Jun 16, 2026 18w ago | 8-K | $1.82 $1.88 | ▲ +3.30% | ▲ +4.55% | $0.9400 (−48.35%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers